Director of Clinical Operations for Cardiology | News | Loyola Medicine
Tuesday, September 20, 2016

Verghese Mathew, MD, FACC, FSCAI, Named Director of Clinical Operations for Loyola's Division of Cardiology

Verghese Mathew, MD

MAYWOOD, IL –  Verghese Mathew, MD, FACC, FSCAI, a nationally known interventional cardiologist, has been named director of clinical operations for Loyola Medicine’s division of cardiology.

Dr. Mathew comes to Loyola from Mayo Clinic, where he held several leadership positions in the cardiac and vascular areas.

Working in conjunction with cardiology chair David Wilber, MD, FAHA, FACC, Dr. Mathew will manage clinical cardiology programs and augment the division’s research and educational enterprises. Dr. Mathew is a professor in the division of cardiology in the department of medicine of Loyola University Chicago Stritch School of Medicine, his medical school alma mater.

“Dr. Mathew brings a wealth of both clinical and research expertise to Loyola,” Dr. Wilber said. “He will play an increasingly important role in enhancing the division's regional and national profile, and in the supervision of our cardiovascular disease programs.”

Dr. Mathew said Loyola’s cardiovascular service line has tremendous talent and a decades-long reputation for clinical excellence. “I look forward to providing state-of-the-art cardiovascular care, and advancing the academic mission and profile of the cardiology division in conjunction with all our physicians and staff,” he said.

With a keen interest in integrated models of care, Dr. Mathew focuses on the application of advanced cardiovascular diagnostic and therapeutic modalities to appropriate patient subsets.

Dr. Mathew has extensive clinical and research experience in interventional cardiology, including complex coronary artery disease, peripheral artery disease and aortic valve disease. Interventional cardiology is a subspecialty of cardiology that uses catheter-based techniques and devices, such stents, to treat coronary and vascular disease. Dr. Mathew has been an investigator in many trials that have evaluated and led to the approval of currently used technologies, such as coronary stents, drug eluting stents (which reduce the likelihood of re-narrowing within stents) and transcatheter aortic valve replacement (TAVR).

TAVR is much less invasive than traditional open-heart surgery, which often requires a sternotomy (splitting the breastbone). The TAVR device is deployed through a catheter that’s inserted in an artery in the groin or a small incision in the chest. TAVR is now approved for patients who are at above-average risk for open heart surgery. Dr. Mathew predicts TAVR eventually will become available to patients who are healthy enough to tolerate open heart surgery.

Dr. Mathew has also played an important role in many trials evaluating various cardiac medications, especially anti-platelet and anti-coagulant drugs used in conjunction with stent procedures. He has played a pivotal role in TAILOR-PCI, an NIH sponsored trial lead by Mayo Clinic and University of Toronto. TAILOR-PCI is testing a personalized medicine approach to choosing appropriate antiplatelet therapy after stent placement.

Dr. Mathew has written or co-authored more than 125 peer-reviewed papers, editorials and invited commentaries, along with numerous book chapters. He has been an invited speaker at many national and international medical conferences.

Dr. Mathew grew up in Chicago and the Chicago suburbs, and earned his medical degree from Loyola’s Stritch School of Medicine. “Returning to Chicago and Loyola after 26 years is a double homecoming for me,” he said.

Dr. Mathew completed a residency in internal medicine and fellowships in cardiovascular diseases and interventional cardiology at Mayo Clinic. He is board certified in interventional cardiology and cardiovascular diseases. He is a Fellow of the American College of Cardiology and a Fellow of the Society for Cardiovascular Angiography and Interventions.

Loyola Medicine is nationally recognized for its expertise in diagnosing and treating a broad range of heart and vascular conditions, including coronary artery disease, heart failure, heart rhythm disorders, hypertension, stroke, valvular disease, vascular disease and pediatric heart conditions

About Loyola Medicine and Trinity Health

Loyola Medicine, a member of Trinity Health, is a quaternary care system based in the western suburbs of Chicago that includes Loyola University Medical Center (LUMC), Gottlieb Memorial Hospital, MacNeal Hospital and convenient locations offering primary and specialty care services from 1,877 physicians throughout Cook, Will and DuPage counties. LUMC is a 547-licensed-bed hospital in Maywood that includes the William G. and Mary A. Ryan Center for Heart & Vascular Medicine, the Cardinal Bernardin Cancer Center, a Level 1 trauma center, Illinois's largest burn center, a certified comprehensive stroke center and a children’s hospital. Having delivered compassionate care for over 50 years, Loyola also trains the next generation of caregivers through its teaching affiliation with Loyola University Chicago’s Stritch School of Medicine and Marcella Niehoff School of Nursing. Gottlieb is a 247-licensed-bed community hospital in Melrose Park with 150 physician offices, an adult day care program, the Gottlieb Center for Fitness, the Loyola Center for Metabolic Surgery and Bariatric Care and the Loyola Cancer Care & Research at the Marjorie G. Weinberg Cancer Center at Melrose Park. MacNeal Hospital is a 374-bed teaching hospital in Berwyn with advanced inpatient and outpatient medical, surgical and psychiatric services, advanced diagnostics and treatments. MacNeal has a 12-bed acute rehabilitation unit, a 25-bed inpatient skilled nursing facility, and a 68-bed behavioral health program and community clinics. MacNeal has provided quality, patient-centered care to the near west suburbs since 1919.

Trinity Health is one of the largest multi-institutional Catholic healthcare systems in the nation, serving diverse communities that include more than 30 million people across 22 states. Trinity Health includes 92 hospitals, as well as 109 continuing care locations that include PACE programs, senior living facilities and home care and hospice services. Its continuing care programs provide nearly 2.5 million visits annually. Based in Livonia, Mich., and with annual operating revenues of $18.3 billion and assets of $26.2 billion, the organization returns $1.1 billion to its communities annually in the form of charity care and other community benefit programs. Trinity employs about 129,000 colleagues, including 7,800 employed physicians and clinicians. Committed to those who are poor and underserved in its communities, Trinity is known for its focus on the country's aging population. As a single, unified ministry, the organization is the innovator of Senior Emergency Departments, the largest not-for-profit provider of home health care services—ranked by number of visits—in the nation, as well as the nation’s leading provider of PACE (Program of All Inclusive Care for the Elderly) based on the number of available programs.